GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Trulieve Cannabis Corp (OTCPK:TCNNF) » Definitions » EBIT

TCNNF (Trulieve Cannabis) EBIT : $133 Mil (TTM As of Sep. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Trulieve Cannabis EBIT?

Trulieve Cannabis's earnings before interest and taxes (EBIT) for the three months ended in Sep. 2024 was $5 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Sep. 2024 was $133 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Trulieve Cannabis's annualized ROC % for the quarter that ended in Sep. 2024 was -2.83%. Trulieve Cannabis's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2024 was 1.80%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Trulieve Cannabis's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2024 was 9.95%.


Trulieve Cannabis EBIT Historical Data

The historical data trend for Trulieve Cannabis's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Trulieve Cannabis EBIT Chart

Trulieve Cannabis Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 112.73 177.69 205.37 54.18 -202.97

Trulieve Cannabis Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 34.56 29.47 46.62 51.96 4.62

Competitive Comparison of Trulieve Cannabis's EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Trulieve Cannabis's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Trulieve Cannabis's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Trulieve Cannabis's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Trulieve Cannabis's EV-to-EBIT falls into.



Trulieve Cannabis EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $133 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Trulieve Cannabis  (OTCPK:TCNNF) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Trulieve Cannabis's annualized ROC % for the quarter that ended in Sep. 2024 is calculated as:

ROC % (Q: Sep. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2024 ) + Invested Capital (Q: Sep. 2024 ))/ count )
=-14.712 * ( 1 - -369.11% )/( (2422.499 + 2460.347)/ 2 )
=-69.0154632/2441.423
=-2.83 %

where

Invested Capital(Q: Jun. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=2864.897 - 87.214 - ( 355.184 - max(0, 123.801 - 631.082+355.184))
=2422.499

Invested Capital(Q: Sep. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=2874.243 - 96.051 - ( 317.845 - max(0, 136.693 - 603.011+317.845))
=2460.347

Note: The Operating Income data used here is four times the quarterly (Sep. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Trulieve Cannabis's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Sep. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2024  Q: Sep. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=18.488/( ( (839.193 + max(168.022, 0)) + (883.246 + max(166.748, 0)) )/ 2 )
=18.488/( ( 1007.215 + 1049.994 )/ 2 )
=18.488/1028.6045
=1.80 %

where Working Capital is:

Working Capital(Q: Jun. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(7.534 + 207.634 + 52.195) - (87.214 + 4.316 + 7.811)
=168.022

Working Capital(Q: Sep. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(9.031 + 220.916 + 47.605) - (96.051 + 6.663 + 8.09)
=166.748

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Trulieve Cannabis's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Sep. 2024 )
=132.659/1333.781
=9.95 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Trulieve Cannabis EBIT Related Terms

Thank you for viewing the detailed overview of Trulieve Cannabis's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Trulieve Cannabis Business Description

Traded in Other Exchanges
Address
6749 Ben Bostic Road, Quincy, FL, USA, 32351
Trulieve Cannabis Corp is a vertically integrated seed to sale and fully licensed medical marijuana company. It is mainly engaged in the cultivation, possession, use, sale, and distribution of medical cannabis.
Executives
Timothy E Mullany officer: Chief Financial Officer 3551 PLANO PARKWAY, THE COLONY TX 75056
Ryan Blust officer: Chief Financial Officer 6749 BEN BOSTIC ROAD, QUINCY FL 32351
Joy Malivuk officer: Chief Accounting Officer 6749 BEN BOSTIC ROAD, QUINCY FL 32351
Peter Healy director C/O TRULIEVE CANNABIS CORP., 6749 BEN BOSTIC ROAD, QUINCY FL 32351
Rebecca L. Young officer: Chief Accounting Officer C/O TRULIEVE CANNABIS CORP., 6749 BEN BOSTIC ROAD, QUINCY FL 32351
Kim A. Rivers director, 10 percent owner, officer: Chief Executive Officer C/O TRULIEVE CANNABIS CORP., 6749 BEN BOSTIC ROAD, QUINCY FL 32351
Thomas L Millner director, 10 percent owner
Thad Beshears director, 10 percent owner C/O TRULIEVE CANNABIS CORP., 6749 BEN BOSTIC ROAD, QUINCY FL 32351
Kyle Landrum officer: Chief Production Officer C/O TRULIEVE CANNABIS CORP., 6749 BEN BOSTIC ROAD, QUINCY FL 32351
Timothy Morey officer: Chief Sales Officer C/O TRULIEVE CANNABIS CORP., 6749 BEN BOSTIC ROAD, QUINCY FL 32351
Eric Powers officer: GC and Corporate Secretary C/O TRULIEVE CANNABIS CORP., 6749 BEN BOSTIC ROAD, QUINCY FL 32351
Susan Thronson director C/O ANGIE'S LIST, INC., 1030 E. WASHINGTON STREET, INDIANPOLIS IN 46202
Alex D'amico officer: Chief Financial Officer 10 EAST PASSAIC AVENUE, UNIT C-2, NUTLEY NJ 07110
Giannella Alvarez director C/O DOMTAR CORPORATION, 234 KINGSLEY PARK DRIVE, FORT MILL SC 29715
Jane C Morreau director